Feature

Is ChatGPT a friend or foe of medical publishing?


 

New rules

But despite how individual researchers feel about LLMs, they agree that these AI tools are here to stay.

“I think that we should anticipate that they will become part of the medical research establishment over time, when we figure out how to use them appropriately,” Dr. Solomon said.

While the debate of how to best use AI in medical publications will continue, journal editors agree that all authors of a manuscript are solely responsible for content in articles that used AI-assisted technology.

“Authors should carefully review and edit the result because AI can generate authoritative-sounding output that can be incorrect, incomplete, or biased,” the ICMJE guidelines state. “Authors should be able to assert that there is no plagiarism in their paper, including in text and images produced by the AI.” This includes appropriate attribution of all cited materials.

The committee also recommends that authors write in both the cover letter and submitted work how AI was used in the manuscript writing process. Recently updated guidelines from the World Association of Medical Editors recommend that all prompts used to generate new text or analytical work should be provided in submitted work. Dr. Greene also noted that if authors used an AI tool to revise their work, they can include a version of the manuscript untouched by LLMs.

It is similar to a preprint, he said, but rather than publishing a version of a paper prior to peer review, someone is showing a version of a manuscript before it was reviewed and revised by AI. “This type of practice could be a path that lets us benefit from these models,” he said, “without having the drawbacks that many are concerned about.”

Dr. Solomon has financial relationships with AbbVie, Amgen, Janssen, CorEvitas, and Moderna. Both Dr. Greene and Dr. Pividori are inventors in the U.S. Provisional Patent Application No. 63/486,706 that the University of Colorado has filed for the “Publishing Infrastructure For AI-Assisted Academic Authoring” invention with the U.S. Patent and Trademark Office. Dr. Greene and Dr. Pividori also received a grant from the Alfred P. Sloan Foundation to improve their AI-based manuscript revision tool. Dr. Gao reported no relevant financial relationships.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Teledermatology follow-up after Mohs surgery gets a thumbs up from patients
MDedge Dermatology
Docs fervently hope federal ban on noncompete clauses goes through
MDedge Dermatology
Morning PT
MDedge Dermatology
Pop this question to improve medication adherence
MDedge Dermatology
AI at the office: Are clinicians prepared?
MDedge Dermatology
People still want their medical intelligence in human form
MDedge Dermatology
States move to curb insurers’ prior authorization requirements as federal reforms lag
MDedge Dermatology
As Medicaid purge begins, ‘staggering numbers’ of Americans lose coverage
MDedge Dermatology
How can we make medical training less ‘toxic’?
MDedge Dermatology
The enemy of carcinogenic fumes is my friendly begonia
MDedge Dermatology